105 related articles for article (PubMed ID: 1872924)
1. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins.
Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Takamatsu S
Atherosclerosis; 1991 Mar; 87(1):47-55. PubMed ID: 1872924
[TBL] [Abstract][Full Text] [Related]
2. Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking.
Imaizumi T
Lipids; 1991 Dec; 26(12):1269-73. PubMed ID: 1840278
[TBL] [Abstract][Full Text] [Related]
3. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
Imaizumi T; Satoh K; Yoshida H; Kawamura Y; Hiramoto M; Koyanagi M; Takamatsu S; Takamatsu M
Heart Vessels; 1990; 5(2):81-6. PubMed ID: 2354992
[TBL] [Abstract][Full Text] [Related]
4. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
[TBL] [Abstract][Full Text] [Related]
5. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.
McCall MR; La Belle M; Forte TM; Krauss RM; Takanami Y; Tribble DL
Biochim Biophys Acta; 1999 Jan; 1437(1):23-36. PubMed ID: 9931415
[TBL] [Abstract][Full Text] [Related]
6. The role of lipoproteins in the degradation of platelet-activating factor.
Ostermann G; Kertscher HP; Winkler L; Schlag B; Rühling K; Till U
Thromb Res; 1986 Nov; 44(3):303-14. PubMed ID: 3798402
[TBL] [Abstract][Full Text] [Related]
7. Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis.
Sturm MJ; Strophair JM; Kendrew PJ; Vandongen R; Beilin LJ; Taylor RR
Clin Exp Pharmacol Physiol; 1989 Jul; 16(7):597-605. PubMed ID: 2805433
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke.
Satoh K; Imaizumi T; Yoshida H; Hiramoto M; Takamatsu S
Acta Neurol Scand; 1992 Feb; 85(2):122-7. PubMed ID: 1574985
[TBL] [Abstract][Full Text] [Related]
9. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
[TBL] [Abstract][Full Text] [Related]
10. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin.
Blache D; Bouthillier D; Davignon J
Atherosclerosis; 1992 Apr; 93(3):179-88. PubMed ID: 1534226
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid, lipoprotein-cholesterol and apolipoproteins A-I and B of smoking and non-smoking males.
Sirisali K; Kanluan T; Poungvarin N; Prabhant C
J Med Assoc Thai; 1992 Dec; 75(12):709-13. PubMed ID: 1308540
[TBL] [Abstract][Full Text] [Related]
12. Influence of smoking on serum lipid and lipoprotein levels among family medicine patients.
Batic-Mujanovic O; Beganlic A; Salihefendic N; Pranjic N; Kusljugic Z
Med Arh; 2008; 62(5-6):264-7. PubMed ID: 19469266
[TBL] [Abstract][Full Text] [Related]
13. Serum lipids & lipoprotein profiles of cigarette smokers & passive smokers.
Whig J; Singh CB; Soni GL; Bansal AK
Indian J Med Res; 1992 Oct; 96():282-7. PubMed ID: 1459670
[TBL] [Abstract][Full Text] [Related]
14. Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related.
Taylor RR; Sturm M; Vandongen R; Strophair J; Beilin LJ
Clin Exp Pharmacol Physiol; 1987 Aug; 14(8):665-71. PubMed ID: 3440324
[TBL] [Abstract][Full Text] [Related]
15. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
Stephens CJ; Graham RM; Yadava OP; Leong LL; Sturm MJ; Taylor RR
Cardiovasc Res; 1992 Jan; 26(1):25-31. PubMed ID: 1516109
[TBL] [Abstract][Full Text] [Related]
16. The relationship between insulin resistance and dyslipidaemia in cigarette smokers.
Farin HM; Abbasi F; Kim SH; Lamendola C; McLaughlin T; Reaven GM
Diabetes Obes Metab; 2007 Jan; 9(1):65-9. PubMed ID: 17199720
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis.
Craig WY; Palomaki GE; Johnson AM; Haddow JE
Pediatrics; 1990 Feb; 85(2):155-8. PubMed ID: 2136949
[TBL] [Abstract][Full Text] [Related]
20. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
Kulikov VI; Bergel'son LD
Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
